Kate MacQueen, PhD, MPH

Senior Scientist, Social and Behavioral Health Sciences

Areas of expertise

  • Social, behavioral and ethical aspects of biomedical HIV prevention trials
  • Community-based participatory research
  • Stakeholder engagement
  • Mixed methods research
  • Gender dynamics

Projects & Resources

  • The Building Healthy Communities project is focused on building evidence that integrated, multisector efforts to improve community health are more effective than nonintegrated approaches.

  • FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.

Published Research

  • Developing a framework for evaluating ethical outcomes of good participatory practices in TB clinical drug trials
    MacQueen KM, Eley NT, Frick M, Mingote LR, Chou A, Seidel SS, Hannah S, Hamilton C
    J Empir Res Hum Res Ethics 2016 Jul; 11(3): 203-13. [Journal Impact Factor: 1.146]

    With the growing acceptance of community engagement and participatory strategies in clinical research, evaluation of the benefits and burdens are needed. Working with global tuberculosis (TB) stakeholders, the authors developed a theory of change evaluation framework for the Good Participatory Practice Guidelines for TB Drug Trials. The framework is a first step in systematically evaluating participatory research in clinical trials.

Explore More Related to Kate MacQueen, PhD, MPH